A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb

por Wu, Yang, Chen, Dan, Lu, Ya, Dong, Shu-Chen, Ma, Rong, Tang, Wei-yan, Wu, Jian-qiu, Feng, Ji-Feng, Wu, Jian-Zhong
Publicado 2021